PRIVI SPECIALITY CHEMICALS LIMITED Annual Report 2020-21

188 PRIVI SPECIALITY CHEMICALS LIMITED (Formerly known as Fairchem Speciality Limited) (d) Disaggregation of revenue from contract with customers: Particulars Revenue from contracts with customers (IND AS 115) March 31, 2021 Revenue from contracts with customers (IND AS 115) March 31, 2020 (Restated) India 33,853.82 35,301.69 Europe (excluding UK) 31,661.76 28,503.52 North America 28,013.18 27,651.20 Asia (excluding India) 12,643.72 16,547.26 Middle East 7,716.07 8,699.00 United Kingdom 6,198.93 6,360.97 South America 2,871.73 4,012.01 Africa 3,707.93 3,234.87 Australia and New Zealand 143.26 70.61 1,26,810.40 1,30,381.13 (e) Unsatisfied Performance Obligations The Group applies the practical expedient in Paragraph 121 of Ind AS 115 and does not disclose information about remaining performance obligations. 41 Interests in Other Entities (a) Subsidiaries The group’s subsidiaries at March 31, 2021 are set out below. Unless otherwise stated, they have share capital consisting solely of equity shares that are held directly by the group, and the proportion of ownership interests held equals the voting rights held by the group. The country of incorporation or registration is also their principal place of business. Name of the entity Principal activities Place of business/country of incorporation Ownership interest held by the Group March 31, 2021 March 31, 2020 (Restated) Privi Biotechnologies Private Limited Chemicals India 100 100 Privi organics USA Corporation Chemicals United States of America 100 100 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS for the year ended March 31, 2021 (Currency: Indian Rupees in lakhs) 40 Revenue from Contracts with Customers (continued)